EFM
UTHR icon

E Fund Management’s United Therapeutics UTHR Stock Holding History

E Fund Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Sell
762
-309
-29% -$174K 0.01% 321
2026
Q1 		$635K Buy
+1,071
New +$533K 0.02% 232
2025
Q2 		$1.12M Buy
3,881
+591
+18% +$177K 0.05% 156
2025
Q1 		$1.01M Buy
3,290
+655
+25% +$224K 0.05% 168
2024
Q4 		$930K Sell
2,635
-569
-18% -$209K 0.05% 154
2024
Q3 		$1.15M Sell
3,204
-704
-18% -$238K 0.06% 132
2024
Q2 		$1.24M Buy
3,908
+2,125
+119% +$562K 0.07% 108
2024
Q1 		$410K Sell
1,783
-205
-10% -$46.3K 0.03% 210
2023
Q4 		$437K Sell
1,988
-44
-2% -$10.1K 0.03% 185
2023
Q3 		$459K Buy
2,032
+77
+4% +$17.7K 0.03% 135
2023
Q2 		$432K Buy
1,955
+266
+16% +$58.9K 0.03% 146
2023
Q1 		$378K Buy
1,689
+181
+12% +$44.6K 0.03% 185
2022
Q4 		$419K Sell
1,508
-623
-29% -$157K 0.03% 173
2022
Q3 		$446K Buy
2,131
+146
+7% +$32.6K 0.04% 148
2022
Q2 		$468K Buy
1,985
+434
+28% +$88.2K 0.04% 156
2022
Q1 		$278K Buy
+1,551
New +$295K 0.01% 226

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

E Fund Management's UTHR Position: Q2 2026 in Review

E Fund Management reduced its United Therapeutics (UTHR) stake by 29% in Q2 2026, selling an estimated $174K and leaving 762 shares worth $413K. The position accounts for 0.01% of the portfolio, ranked #321.

E Fund Management first reported a position in UTHR in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.24M in Q2 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • E Fund Management held 762 shares of United Therapeutics worth $413K as of Q2 2026.
  • E Fund Management sold 309 United Therapeutics shares in Q2 2026, an estimated $174K.
  • United Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #321 holding.
  • E Fund Management first reported a position in United Therapeutics in Q1 2022 and has held it in 16 quarters since.
  • E Fund Management's United Therapeutics position peaked at $1.24M in Q2 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.